Federal Register / Vol. 86, No. 176 / Wednesday, September 15, 2021 / Notices 51387 

to intervene shall be served by the 

requestor or petitioner in accordance 

with 10 CFR 110.89(a), either by 

delivery, by mail, or filed with the NRC 

electronically in accordance with the 

NRC’s E-Filing rule (72 FR 49139; 

August 28, 2007, as amended at 77 FR 

46562; August 3, 2012). Detailed 

guidance on making electronic 

submissions may be found in the 

Guidance for Electronic Submissions to 

the NRC and on the NRC website at 

https://www.nrc.gov/site-help/esubmittals.html. 

To comply with the procedural 

requirements of E-Filing, at least 10 

days prior to the filing deadline, the 

participant should contact the Office of 

the Secretary by email at 

Hearing.Docket@nrc.gov, or by 

telephone at 301–415–1677, to (1) 

request a digital identification (ID) 

certificate, which allows the participant 

(or its counsel or representative) to 

digitally sign submissions and access 

the E-Filing system for any proceeding 

in which it is participating; and (2) 

advise the Secretary that the participant 

will be submitting a petition or other 

adjudicatory document (even in 

instances in which the participant, or its 

counsel or representative, already holds 

an NRC-issued digital ID certificate). 

Based upon this information, the 

Secretary will establish an electronic 

docket for the hearing in this proceeding 

if the Secretary has not already 

established an electronic docket. 

The information concerning this 

application for an export license 

follows. 

NRC EXPORT LICENSE APPLICATION

Application Information 

Name of Applicant .............................................. Perma-Fix Northwest Richland, Inc. (PFNW). 

Date of Application ............................................. July 2, 2021. 

Date Received .................................................... July 8, 2021. 

Application No ..................................................... XW028. 

Docket No ........................................................... 11006420. 

ADAMS Accession No ........................................ ML21190A131. 

Description of Material 

Material Type ...................................................... Radioactive material consisting of liquid waste generated from medical isotope and radiopharmaceuticals production. The treated waste exported to Canada consists mainly of thermal treatment residual (ash) and some non-combustible metal. 

Total Quantity ..................................................... Authorization to export a total maximum quantity of waste will not exceed 1,379,102 kilograms. 

The maximum isotopic activity returned will be 3.99 TBq. Radionuclides potentially present 

in the waste include: Cd-115, Co-60, Cr-51, Cu-64, ln-115m, K-42, Mo-93m, Mo-99, Nb91m, Nb-92m, Nb-95, Nb-95m, Nb-96, Re-188, Sb-122, Sb-124, Ta-182, Ta-183, Tc-99m, 

W-185, W-187, W-188, and Zr-89. 

End Use .............................................................. Disposal in Canada. 

Country of Destination ........................................ Canada. 

Dated: September 9, 2021. 

For the Nuclear Regulatory Commission. 

David L. Skeen, 

Deputy Director, Office of International 

Programs. 

[FR Doc. 2021–19840 Filed 9–14–21; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 11006421; NRC–2021–0164] 

Perma-Fix Northwest Richland, Inc. 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Export license application; 

opportunity to provide comments, 

request a hearing, and petition for leave 

to intervene. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) received and is 

considering issuing an export license 

(XW029) requested by Perma-Fix 

Northwest Richland, Inc. (PFNW). On 

July 2, 2021, PFNW filed an application 

with the NRC for a license authorizing 

the export of low-level radioactive waste 

to BWXT Medical, Ltd., Canada. The 

NRC is providing notice of the 

opportunity to comment, request a 

hearing, and petition to intervene on 

PFNW’s application. 

DATES: Submit comments by October 15, 

2021. A request for a hearing or a 

petition for leave to intervene must be 

filed by October 15, 2021. 

ADDRESSES: You may submit comments 

by any of the following methods; 

however, the NRC encourages electronic 

comment submission through the 

Federal Rulemaking website: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2021–0164. Address 

questions about Docket IDs in 

Regulations.gov to Stacy Schumann; 

telephone: 301–415–0624; email: 

Stacy.Schumann@nrc.gov. For technical 

questions contact the individual listed 

in the FOR FURTHER INFORMATION

CONTACT section of this document. 

• Email comments to: 

Hearing.Docket@nrc.gov. If you do not 

receive an automatic email reply 

confirming receipt, then contact us at 

301–415–1677. 

• Fax comments to: Secretary, U.S. 

Nuclear Regulatory Commission at 301– 

415–1101. 

• Mail comments to: Secretary, U.S. 

Nuclear Regulatory Commission, 

Washington, DC 20555–0001, ATTN: 

Rulemakings and Adjudications Staff. 

For additional direction on obtaining 

information and submitting comments, 

see ‘‘Obtaining Information and 

Submitting Comments’’ in the 

SUPPLEMENTARY INFORMATION section of 

this document. 

FOR FURTHER INFORMATION CONTACT: Gary 

Langlie, Office of International 

Programs, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001; telephone: 301–287–9076, email: 

Gary.Langlie@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and 

Submitting Comments 

A. Obtaining Information 

Please refer to NRC–2021–0164 or 

Docket No. 11006421 when contacting 

the NRC about the availability of 

information for this action. You may 

obtain publicly available information 


khammond on DSKJM1Z7X2PROD with NOTICES
51388 Federal Register / Vol. 86, No. 176 / Wednesday, September 15, 2021 / Notices 

related to this action by the following 

methods: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2021–0164. 

• NRC’s Public Website: Go to https:// 

www.nrc.gov and search for XW029, 

Docket No. 11006421, or Docket ID 

NRC–2021–0164. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, 301– 

415–4737, or by email to pdr.resource@

nrc.gov. The export license application 

from PFNW is available in ADAMS 

under Accession No. ML21190A133. 

• Attention: The PDR, where you may 

examine and order copies of public 

documents, is currently closed. You 

may submit your request to the PDR via 

email at pdr.resource@nrc.gov or call 1– 

800–397–4209 or 301–415–4737, 

between 8:00 a.m. and 4:00 p.m. (ET), 

Monday through Friday, except Federal 

holidays. 

B. Submitting Comments 

The NRC encourages electronic 

comment submission through the 

Federal Rulemaking website (https://

www.regulations.gov). Please include 

NRC–2021–0164 or Docket No. 

11006421 in your comment submission. 

The NRC cautions you not to include 

identifying or contact information that 

you do not want to be publicly 

disclosed in your comment submission. 

The NRC will post all comment 

submissions at https://

www.regulations.gov as well as enter the 

comment submissions into ADAMS. 

The NRC does not routinely edit 

comment submissions to remove 

identifying or contact information. 

If you are requesting or aggregating 

comments from other persons for 

submission to the NRC, then you should 

inform those persons not to include 

identifying or contact information that 

they do not want to be publicly 

disclosed in their comment submission. 

Your request should state that the NRC 

does not routinely edit comment 

submissions to remove such information 

before making the comment 

submissions available to the public or 

entering the comment into ADAMS. 

II. Discussion 

On July 8, 2021, the NRC received an 

application from PFNW requesting a 

specific license to export low-level 

radioactive waste to Canada. The 

application seeks authorization to 

export no greater than 1,379,102 

kilograms and 3.99 terabecquerels (TBq) 

of liquid low-level radioactive waste 

generated from medical isotope and 

radiopharmaceuticals production. The 

application requests an expiration date 

of December 1, 2026. 

In accordance with section 110.70 

paragraph (b) of title 10 of the Code of 

Federal Regulations (10 CFR) the NRC is 

providing notice of the receipt of the 

application; providing the opportunity 

to submit written comments concerning 

the application; and providing the 

opportunity to request a hearing or 

petition for leave to intervene, for a 

period of 30 days after publication of 

this notice in the Federal Register. A 

hearing request or petition for leave to 

intervene must include the information 

specified in 10 CFR 110.82(b). Any 

request for hearing or petition for leave 

to intervene shall be served by the 

requestor or petitioner in accordance 

with 10 CFR 110.89(a), either by 

delivery, by mail, or filed with the NRC 

electronically in accordance with the 

NRC’s E-Filing rule (72 FR 49139; 

August 28, 2007, as amended at 77 FR 

46562; August 3, 2012). Detailed 

guidance on making electronic 

submissions may be found in the 

Guidance for Electronic Submissions to 

the NRC and on the NRC website at 

https://www.nrc.gov/site-help/esubmittals.html. 

To comply with the procedural 

requirements of E-Filing, at least 10 

days prior to the filing deadline, the 

participant should contact the Office of 

the Secretary by email at 

Hearing.Docket@nrc.gov, or by 

telephone at 301–415–1677, to (1) 

request a digital identification (ID) 

certificate, which allows the participant 

(or its counsel or representative) to 

digitally sign submissions and access 

the E-Filing system for any proceeding 

in which it is participating; and (2) 

advise the Secretary that the participant 

will be submitting a petition or other 

adjudicatory document (even in 

instances in which the participant, or its 

counsel or representative, already holds 

an NRC-issued digital ID certificate). 

Based upon this information, the 

Secretary will establish an electronic 

docket for the hearing in this proceeding 

if the Secretary has not already 

established an electronic docket. 

The information concerning this 

application for an export license 

follows. 

NRC EXPORT LICENSE APPLICATION

Application Information 

Name of Applicant ....................................... Perma-Fix Northwest Richland, Inc. (PFNW). 

Date of Application ...................................... July 2, 2021. 

Date Received ............................................. July 8, 2021. 

Application No ............................................. XW029. 

Docket No .................................................... 11006421. 

ADAMS Accession No ................................. ML21190A133. 

Description of Material 

Material Type ............................................... Radioactive material consisting of liquid waste generated from medical isotope and radiopharmaceuticals production. The treated waste exported to Canada consists mainly of thermal treatment residual (ash) and some non-combustible metal. 

Total Quantity .............................................. Authorization to export a total maximum quantity of waste will not exceed 1,379,102 kilograms. 

The maximum isotopic activity returned will be 3.99 TBq. Radionuclides potentially present 

in the waste include: Cd-115, Co-60, Cr-51, Cu-64, ln-115m, K-42, Mo-93m, Mo-99, Nb91m, Nb-92m, Nb-95, Nb-95m, Nb-96, Re-188, Sb-122, Sb-124, Ta-182, Ta-183, Tc-99m, 

W-185, W-187, W-188, and Zr-89. 

End Use ....................................................... Disposal in Canada. 

Country of Destination ................................. Canada. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 176 / Wednesday, September 15, 2021 / Notices 51389 

Dated: September 9, 2021. 

For the Nuclear Regulatory Commission. 

David L. Skeen, 

Deputy Director, Office of International 

Programs. 

[FR Doc. 2021–19841 Filed 9–14–21; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 50–482; NRC–2020–0110] 

Issuance of Exemption in Response to 

COVID–19 Public Health Emergency 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Exemption; issuance. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) issued one 

exemption in August 2021 in response 

to a request from one licensee for relief 

due to the coronavirus 2019 disease 

(COVID–19) public health emergency 

(PHE). The exemption affords the 

licensee temporary relief from certain 

requirements under NRC regulations. 

DATES: On August 25, 2021, the NRC 

granted one exemption in response to a 

request submitted by one licensee on 

July 29, 2021, as supplemented by letter 

dated August 12, 2021. 

ADDRESSES: Please refer to Docket ID 

NRC–2020–0110 when contacting the 

NRC about the availability of 

information regarding this document. 

You may obtain publicly available 

information related to this document 

using any of the following methods: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2020–0110. Address 

questions about Docket IDs in 

Regulations.gov to Stacy Schumann; 

telephone: 301–415–0624; email: 

Stacy.Schumann@nrc.gov. For technical 

questions, contact the individual listed 

in the FOR FURTHER INFORMATION

CONTACT section of this document. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, 301– 

415–4737, or by email to pdr.resource@

nrc.gov. For the convenience of the 

reader, instructions about obtaining 

materials referenced in this document 

are provided in the ‘‘Availability of 

Documents’’ section. 

• Attention: The PDR, where you may 

examine and order copies of public 

documents, is currently closed. You 

may submit your request for copies of 

documents to the PDR via email at 

pdr.resource@nrc.gov or call 1–800– 

397–4209 or 301–415–4737, between 

8:00 a.m. and 4:00 p.m. (ET), Monday 

through Friday, except Federal holidays. 

FOR FURTHER INFORMATION CONTACT: 

James Danna, Office of Nuclear Reactor 

Regulation, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001; telephone: 301–415–7422, email: 

James.Danna@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Introduction 

On August 25, 2021, the NRC granted 

one exemption in response to a request 

submitted by one licensee dated July 29, 

2021, as supplemented by letter dated 

August 12, 2021. The exemption 

temporarily allows the licensee to 

deviate from certain requirements of 

chapter I of title 10 of the Code of 

Federal Regulations (10 CFR), part 50, 

appendix E, ‘‘Emergency Planning and 

Preparedness for Production and 

Utilization Facilities,’’ section IV.F, 

‘‘Training.’’ 

The exemption grants Wolf Creek 

Nuclear Operating Corporation (for Wolf 

Creek Generating Station, Unit 1), a 

schedular exemption from the offsite 

biennial emergency preparedness (EP) 

exercise requirement, allowing it to 

postpone the calendar year 2021 fullparticipation biennial EP exercise until 

November 30, 2022, or when the 

required exercise is conducted in 

calendar year 2022, whichever occurs 

first. The exemption affords this 

licensee temporary relief from the 

requirements of 10 CFR part 50, 

appendix E, regarding offsite response 

organization (ORO) participation in the 

biennial EP exercise. The exemption 

will not adversely affect the emergency 

response capability of the facility 

because the licensee has conducted 

numerous drills, exercises, and other 

training activities that have exercised 

the licensee’s emergency response 

strategies since the last evaluated 

biennial EP exercise and that State, 

county, and local OROs have 

participated therein. 

The table in this notice provides 

transparency regarding the number and 

type of exemptions the NRC has issued. 

Additionally, the NRC publishes tables 

of approved regulatory actions related to 

the COVID–19 PHE on its public 

website at https://www.nrc.gov/aboutnrc/covid-19/reactors/licensingactions.html. 

II. Availability of Documents 

The table in this notice provides the 

facility name, docket number, document 

description, and ADAMS accession 

number for the exemption issued. 

Additional details on the exemption 

issued, including the exemption request 

submitted by the licensee and the NRC’s 

decision, are provided in the exemption 

approval listed in the table in this 

notice. For additional directions on 

accessing information in ADAMS, see 

the ADDRESSES section of this document. 

WOLF CREEK GENERATING STATION, UNIT 1, DOCKET NO. 50–482 

Document description ADAMS 

Accession No. 

Wolf Creek Nuclear Operating Corporation—Docket No. 50–482: One-Time Request for Exemption from the Biennial Emergency Preparedness, dated July 29, 2021 ................................................................................................................................ ML21210A450 

Wolf Creek Nuclear Operating Corporation—Docket No. 50–482: Supplement to One-Time Request for Exemption from the 

Biennial Emergency Preparedness, dated August 12, 2021 ..................................................................................................... ML21224A225 

Wolf Creek Generating Station, Unit 1—Temporary Exemption from Requirements of 10 CFR part 50, appendix E, sections 

IV.F.2.B and IV.F.2.C (EPID L–2021–LLE–0036 [COVID–19]), dated August 25, 2021 .......................................................... ML21225A024 


khammond on DSKJM1Z7X2PROD with NOTICES